Motif prediction of abemaciclib in a breast cancer cell line using ChIP-Seq data analysis. Biomed. Res. Ther. [Internet]. 2022 Mar. 31 [cited 2024 Nov. 15];9(3):4971-85. Available from: https://preservation.bmrat.org/index.php/BMRAT/article/view/732